Copyright
©The Author(s) 2021.
World J Clin Cases. Sep 16, 2021; 9(26): 7845-7849
Published online Sep 16, 2021. doi: 10.12998/wjcc.v9.i26.7845
Published online Sep 16, 2021. doi: 10.12998/wjcc.v9.i26.7845
Figure 1 Graph of the Epstein-Barr virus-DNA change trend of the patient after PEG-aspargase treatment.
There is a significant decrease after the first PEG-aspargase treatment. After the third course of treatment, the patient's Epstein-Barr virus-DNA (EBV-DNA) turned negative (according to our hospital test standard, EBV-DNA < 500 copies/mL is negative). The arrow indicates the time of for PEG-aspargase treatment. EBV: Epstein-Barr virus.
- Citation: Song DL, Wang JS, Chen LL, Wang Z. Chronic active Epstein-Barr virus infection treated with PEG-aspargase: A case report. World J Clin Cases 2021; 9(26): 7845-7849
- URL: https://www.wjgnet.com/2307-8960/full/v9/i26/7845.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i26.7845